Global market for liver disease diagnostics at $62.6 billion

Portland, OR, Nov. 03, 2022 (GLOBE NEWSWIRE) — According to the report released by Allied Market Research, the Liver Disease Diagnostics Market generated $34.5 billion in 2021 and is expected to reach $62.6 billion by 2031, growing at a CAGR of 6.1% from 2022 to 2031. changing market trends, market size and estimates, value chain, key investment pockets, drivers and opportunities, competitive landscape and regional landscape. The report is a useful source of information for new entrants, shareholders, early adopters and stockholders in introducing necessary strategies for the future and taking essential actions to significantly strengthen and increase their position in the market.

Download a free sample report (PDF of 203 pages with information, graphs, tables, figures): https://www.alliedmarketresearch.com/request-sample/8790

Report coverage and details:

Report cover Details
Forecast period 2022–2031
Market size in 2031 $62.6 billion
CAGR 6.1%
Number of pages in the report 203
Segments Covered Technique, end use and region.
Drivers Increase in unhealthy lifestyles in people
Increased alcohol consumption
Opportunities Increase in demand for minimally invasive diagnostic procedure for diagnosis of liver diseases
Increase in smoking habits in people
holds back Exorbitant cost of treatment


COVID-19 scenario:

  • The COVID-19 outbreak has negatively impacted the growth of the global liver disease diagnostics market, owing to the prevalence of lockdowns in various countries around the world.
  • Lockdowns have resulted in increased focus and reliance on COVID-19 infected patients due to the disease’s high mortality rate. Thus, diagnostic treatments for liver disease have either been postponed or canceled due to the increase in coronavirus cases.
  • Apart from this, the COVID-19 pandemic has led to increased awareness of physical, mental and emotional health. This, in turn, has increased awareness of liver disease diagnosis and increased regular check-ups using liver disease diagnostics. Thus, such development is expected to bring stabilization and boost the growth of the liver disease diagnostics market over the forecast period.

The report offers a detailed segmentation of the global liver disease diagnostics market on the basis of technique, end-use, and region. The report provides a comprehensive analysis of each segment and their respective sub-segment using graphical and tabular representation. This analysis can essentially help market players, investors and new entrants to determine and design strategies based on the fastest growing and highest revenue generating segments mentioned in the report.

Purchase order :
https://www.alliedmarketresearch.com/purchase-enquiry/8790

Based on the technique, the imaging segment held the largest market share in 2021, holding more than two-fifths of the global market, and is expected to maintain its leading status during the forecast period. The laboratory testing segment, on the other hand, is expected to quote the fastest CAGR of 6.6% during the forecast period.

Based on end-use, the hospital segment held the dominant market share in 2021, holding more than two-fifths of the global market, and is expected to maintain its leading status during the forecast period. The laboratory segment, on the other hand, is expected to quote the fastest CAGR of 6.6% during the forecast period.

According to the region, the North American market held the lion’s share in 2021, holding more than two-fifths of the global market, and is expected to maintain its leading status during the forecast period. The Asia-Pacific region, on the other hand, is expected to quote the fastest CAGR of 8.3% during the forecast period. The report also analyzed other market regions such as Europe and LAMEA.

Key players analyzed in the Global Liver Disease Diagnostics Market report include Abbott Laboratories, Bio-Rad Laboratories Inc., Cosara Diagnostics Pvt Ltd, Echosens, Meril Life Sciences Pvt. Ltd., PerkinElmer, Qiagen NV, Siemens AG, Thermo Fisher Scientific Inc., Trivitron Healthcare.

The report analyzes these key players of the global liver disease diagnostics market. These market players have effectively used strategies such as joint ventures, collaborations, expansion, new product launches, partnerships, and others to maximize their foothold and prowess in the industry. The report is useful for analyzing recent developments, product portfolio, business performance, and operating segments of major market players.


Reports on trends in the healthcare industry (book now with 10% discount):

Pharmaceutical packaging market by type of product (parenteral containers, plastic bottles, blister packaging, closures, specialized bags, labels and others), material (glass, aluminum foils, plastics and polymers, paper and cardboard and others): analysis of opportunities and industry forecast, 2020 -2030

In vitro diagnostics market By product and services (reagents, instruments, software and services), by technique (immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, others), by application (infectious diseases, cancer, heart diseases, immune system disorders, Nephrology, Gastrointestinal Diseases, Others), By End-User (Autonomous Laboratories, Hospitals, University & Medical Schools, Point-of-Care, Others): Global Opportunities Analysis and Industry Forecast, 2020-2030

DNA Sequencing Market by product (consumable, instrument and service) application (biomarkers and cancer, diagnostics, reproductive health, personalized medicine, forensics and others), technology (sequencing by synthesis, semiconductor ion sequencing, ligation sequencing, pyrosequencing, real single molecule – temporal sequencing, chain termination sequencing and nanopore sequencing) and end user (academic and government research institutes, pharmaceutical companies, biotechnology companies and hospitals and clinics): analysis of global opportunities and industry forecast, 2020- 2030

Medical tourism market By Type of Treatment (Dental Treatment, Cosmetic Treatment, Cardiovascular Treatment, Orthopedic Treatment, Neurological Treatment, Cancer Treatment, Fertility Treatment and Others): Global Opportunities Analysis and Industry Forecast, 2020-2030

Multiplex Dosing Market by type (protein-based multiplex assays, nucleic acid-based multiplex assay and other multiplex assays), product (reagents and consumables, instruments and accessories, software and services), application (clinical diagnostics, research and development and companion diagnostics ) and End User (Hospitals, Clinical Laboratories, Research Institutes, and Pharmaceutical and Biotech Companies): Global Opportunities Analysis and Industry Forecast, 2020-2030


About Us

Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unparalleled quality of “Market research reportsand “Business Intelligence Solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.

We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. Allied Market Research CEO Pawan Kumar helps inspire and encourage everyone associated with the company to maintain high quality data and help clients in every way possible to achieve success. All data presented in the reports we publish are drawn from primary interviews with senior managers of large companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.

The Web: https://www.alliedmarketresearch.com/reports-store/life-sciences


        

Comments are closed.